A mixture of mrna to enhance the potency of dendritic cells

Kris Thielemans (Inventor)

Research output: Patent

Abstract

The invention is situated in the field of cancer immunotherapy and more specifically the maturation of antigen-presenting cells in order to enhance their potency to induce an immune response.
Original languageEnglish
Patent numberWO2021185824
Publication statusPublished - 2021

Fingerprint

Dive into the research topics of 'A mixture of mrna to enhance the potency of dendritic cells'. Together they form a unique fingerprint.

Cite this